Lyell Immunopharma (LYEL) Prepaid Assets (2020 - 2026)

Lyell Immunopharma (LYEL) has 7 years of Prepaid Assets data on file, last reported at $13.3 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 65.99% year-over-year to $13.3 million; the trailing twelve-month figure through Mar 2026 stood at $13.3 million (up 65.99% YoY), and the FY2025 full-year result was $13.7 million, up 51.31% from the prior year.
• Prepaid Assets declined to $13.3 million in Q1 2026, from $13.7 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $13.7 million in Q4 2025 to a low of $5.4 million in Q2 2025.
• A 5-year average of $10.1 million and a median of $10.7 million in 2023 frame the typical range for Prepaid Assets.
• Across the five-year window, Prepaid Assets plunged 37.69% in 2025 and surged 65.99% in 2026, its largest moves.
• Tracing LYEL's Prepaid Assets over 5 years: stood at $11.1 million in 2022, then dropped by 24.05% to $8.5 million in 2023, then climbed by 7.14% to $9.1 million in 2024, then surged by 51.31% to $13.7 million in 2025, then slipped by 3.19% to $13.3 million in 2026.
• Business Quant data shows LYEL's Prepaid Assets at $13.3 million in Q1 2026, $13.7 million in Q4 2025, and $8.6 million in Q3 2025.